Countries

  • Austria

    The purpose of the Pharmig Code of Conduct is to enable the pharmaceutical industry to meet its responsibility in health care in a professional manner while maintaining the high ethical standards of the pharmaceutical industry. The imperative balance between the ...
  • Belgium

    The present Code of Deontology guarantees that the activities of the pharmaceutical companies in providing information on or advertising the medicinal products they market takes place within a quality scientific framework that takes due account of the justified interests and ...
  • Bulgaria

    The Code of Ethics herein stipulates the principles and the rules that the Companies are obliged to observe during performance of promotion and advertising activities with respect to prescription-only pharmaceuticals intended for healthcare professionals and permitted by the Bulgarian law, ...
  • Croatia

    The Croatian Association of Research Based Pharmaceutical Companies (hereinafter referred to as: the Association) is the representative body of research-oriented manufacturers of medicinal products and medicinal devices that are duly organized and act in the Republic of Croatia in line ...
  • Cyprus

    The Cyprus Association of Research based Companies (KEFEA) Code of Practice, hereinafter called «the Code», covers the promotion of prescription only medicinal products. “Promotion includes every activity undertaken, organised or carried on by a pharmaceutical company or commissioned thereby, promoting ...
  • Czech Republic

    The pharmaceutical industry promotes the concept of good health, and a positive, health-oriented approach to daily living. Recognizing that medicines play a vital role in the prevention, amelioration and treatment of disease states, the industry undertakes: to provide medicines that conform ...
  • Denmark

    Lif, IGL and PFL work to provide the pharmaceutical industry with the best possible conditions to research, develop, market, distribute and inform about medicinal products thus ensuring broad and fast access for patients to the best medical treatment.
  • Estonia

    The code of the Association of Pharmaceutical Manufacturers in Estonia on the Promotion of Prescription Medicines and Cooperation with Healthcare Professionals is based on the EFPIA code on the Promotion of Prescription-Only Medicines to, and Interaction with, Healthcare Professionals, adopted ...
  • Finland

    The objective of the voluntary guidance is to increase the reliability of the marketing of medicines and to promote the information value of the marketing message vis-à-vis the consumers and healthcare professionals, thus contributing to an appropriate use of medicines. ...
  • France

    EFPIA and its members are conscious of the importance of providing accurate, fair and objective information about medicinal products so that rational decisions can be made as to their use. With this in mind, EFPIA has adopted the EFPIA HCP ...
  • Germany

    The members of the association “Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.” (FSA) (“Voluntary Self-regulation for the Pharmaceutical Industry”) have made a commitment to communicate the knowledge required for the appropriate selection and application of pharmaceuticals by disseminating accurate and objective ...
  • Greece

    The SFEE Code of Practice, hereinafter called “the Code”, covers the promotion of prescription only medicinal products. The “promotion” includes any activity, undertaken, organized or carried on by a pharmaceutical company or commissioned thereby, promoting the prescription, supplying, sale, administration ...
  • Hungary

    The Associations represent the specific interests of pharmaceutical companies operating in Hungary. Their members acknowledge their responsibility in devising and implementing ethical pharmaceutical marketing communication, in their effort to provide right and broad ranging information that truly reflects the role ...
  • Ireland

    The Code has been prepared by the Irish Pharmaceutical Healthcare Association (IPHA) with a view to securing the universal acceptance and adoption of high standards of conduc tin the marketing of medicinal products to healthcare professionals, whether intended for use ...
  • Italy

    In order to comply with the provisions of statute law and the rules laid down by the Codes of Conduct of European and international federations of the pharmaceutical industry (EFPIA and IFPMA), Farmindustria has drawn up a Code of Professional ...
  • Latvia

    The Association of International Research-based Pharmaceutical Manufacturers (hereinafter: SIFFA) the Latvian Generic Medicines Association (hereinafter: LPMA), and their members (hereinafter SIFFA, LPMA and their members jointly referred to as Manufacturers) are conscious of the importance of providing accurate, fair and ...
  • Lithuania

    The Code for Pharmaceutical Marketing has been adopted at the will and upon common agreement of IFPA and VGA – associations of companies engaged in pharmaceutical marketing in Lithuania. It seeks to ensure that member pharmaceutical companies engage in an ...
  • Malta

    The Pharmaceutical Research Based Industry Malta Association, PRIMA, is affiliated with EFPIA and its code outlined below is based on the EFPIA code approved on 05/10/2007.
  • Netherlands

    This code of conduct applies to the advertisement of pharmaceuticals in the broadest sense of the word, meaning oral, print, audiovisual methods, exhibitions, conventions and symposia as well as other manners.
  • Norway

    The main responsibility of the Pharmaceutical Industry is to develop new and efficient medicinal products, to improve existing medicinal products, and to provide information to assure that these products will be of use to the individual patient.
  • Poland

    Employers’ Union of Innovative Pharmaceutical Companies INFARMA and its members, being aware of importance of precise communication, reliable and objective information on medicinal products in making rational decisions regarding administration of medicinal products, have approved the Pharmaceutical Industry Code of ...
  • Portugal

    Since 1987 APIFARMA is governed by Codes of Ethics which, as time goes by, have gone under changes as a result of the changes with national and community legislation and the ongoing need to clarify concepts and practices.
  • Romania

    The mission of EFPIA and, implicitly, of ARPIM is to promote the progresses in the pharmaceutical industry due to its technological and economic development in Europe and to assist in bringing to market medicinal products, representing the fruits of the ...
  • Serbia

    The innovative pharmaceutical industry in the Republic of Serbia is committed to benefiting patients by operating in a professional, ethical and transparent manner to ensure the appropriate use of medicines and support the provision of the high quality healthcare. This ...
  • Slovakia

    A. This Code owes its origin to the determination of AIFP* to secure universal acceptance and adherence to high ethical standards in the marketing of prescription- only medicinal products.   B. This Code regulates promotion of prescription-only medicinal products towards authorised persons, promotional activities of ...
  • Slovenia

    The main responsibility of the Pharmaceutical Industry is to develop new and efficient medicinal products, to improve existing medicinal products, and to provide reliable information about these products so that they will be of use to the individual patient.
  • Sweden

    Since they were originally adopted in 1969 by the Swedish Association of the Pharmaceutical Industry (LIF) and the Association of Representatives of Foreign Pharmaceutical Industries (RUFI), the Rules governing medicinal product information have been the primary document for specifying in ...
  • Switzerland

    The Pharma Code puts the above-mentioned codes of the international pharmaceutical industry associations into concrete terms for Switzerland. Code of Conduct of the Pharmaceutical Industry in Switzerland of December 4, 2003, revised on September 6, 2013 (to come into effect January ...
  • Turkey

    Members of the Association of Research-Based Pharmaceutical Companies (AIFD) conduct medical and biopharmaceutical research in order to provide service to patients by offering high quality treatment opportunities. Pharmaceutical companies manufacture, investigate, promote, distribute and sell their drugs in compliance with ...
  • United Kingdom

    The pharmaceutical industry in the United Kingdom is committed to benefiting patients by operating in a professional, ethical and transparent manner to ensure the appropriate use of medicines and support the provision of high quality healthcare. This commitment applies to ...